药物输送装置市场规模、份额和成长分析（按给药途径、应用、最终用途和地区划分）－2026-2033年产业预测

预计到 2024 年，药物输送设备市场规模将达到 2,941.7 亿美元，到 2025 年将达到 3,115.2 亿美元，到 2033 年将达到 4,927.9 亿美元，预测期（2026-2033 年）的复合年增长率为 5.9%。

药物输送装置市场正经历显着成长，这主要得益于先进技术的日益融合，这些技术能够增强标靶药物传输。这些装置透过确保最佳剂量，最大限度地减少副作用，从而降低所需活性成分的总量，最终降低产品成本。人们对新型药物输送解决方案日益增长的兴趣，推动了广泛的研发活动，重点在于提升病患的便利性、可及性和精准度。生物製药产业的蓬勃发展进一步支撑了这一成长趋势，该产业正在催生许多新型治疗方法。此外，製造商对临床试验投入的不断增加，以及监管机构的积极参与，共同创造了有利于创新药物研发的良好环境。

全球药物输送装置市场按给药途径、应用领域、最终用途和地区进行细分。依给药途径划分，可分为口服、吸入、经皮、注射、眼科、鼻腔、局部用药及其他。依应用领域划分，可分为肿瘤、感染疾病、呼吸系统疾病、糖尿病、心血管疾病、自体免疫疾病、中枢神经系统疾病及其他。依最终用途划分，可分为医院、诊断中心、门诊手术中心/诊所、居家医疗机构及其他。依地区划分，可分为北美、欧洲、亚太、拉丁美洲以及中东和非洲。

驱动药物输送设备市场的因素

药物输送设备市场的扩张主要得益于联邦政府不断增加的投资，预计将进一步推动市场成长。此外，医疗产业公共和私营部门的进步，尤其是在发展中地区，有望释放巨大的市场机会。政府旨在为服务不足地区提供感染疾病、呼吸系统疾病、糖尿病和心血管疾病等疾病有效治疗的倡议，进一步增强了市场发展的潜力。资金筹措、医疗保健水准的提高以及针对性措施的结合，将成为推动市场向前发展的动力。

药物输送装置市场的限制因素

药物输送装置市场面临来自多种替代系统的挑战，包括口服药物、静脉注射和经皮吸收贴片，这些系统正在争取使用者青睐。特定给药方式的选择受多种因素影响，包括具体的医疗需求、病患的个人偏好、药物本身的特性。由于医护人员和患者会根据自身情况和需求权衡每种方法的利弊，这些相互竞争的给药方式可能会限制皮下给药装置的成长和普及。因此，市场正面临这些替代解决方案的阻力。

药物输送装置市场趋势

药物输送装置市场呈现强劲成长势头，这主要得益于皮下给药方式的日益普及以及人们对生物相似药和生物製药的关注度不断提高。随着医疗机构寻求针对复杂疾病更精准、更具标靶性的治疗方法，皮下给药系统因其便捷高效而日益受到重视。这种转变不仅透过易用性提高了患者的依从性，也有助于增强生物製药和生物相似药的疗效。因此，製造商正致力于创新设计和先进技术以满足这一需求，并将皮下给药定位为不断发展的药物传输领域中的关键要素。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析及其影响

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 技术进步
• 监管环境
• 价值链分析
• 案例研究分析
• PESTEL 分析
• 市场吸引力指数
• 定价分析

全球药物输送装置市场规模（依给药途径及复合年增长率划分）（2026-2033 年）

• 口服
• 吸入
• 经皮
• 注射
• 眼科
• 鼻腔
• 外用
• 其他的

全球药物传输设备市场规模（按应用及复合年增长率划分）（2026-2033 年）

• 肿瘤学
• 感染疾病
• 呼吸系统疾病
• 糖尿病
• 循环系统疾病
• 自体免疫疾病
• 中枢神经系统疾病
• 其他的

全球药物传输设备市场规模（按最终用途和复合年增长率划分）（2026-2033 年）

• 医院
• 诊断中心
• 门诊手术中心/诊所
• 居家医疗环境
• 其他的

全球药物传输设备市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 英国
  • 德国
  • 西班牙
  • 法国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2021-2023年营收年比比较

主要企业简介

• Pfizer, Inc.
• Novartis AG
• BD
• Bayer AG
• UniQure NV
• Sibiono GeneTech Co. Ltd.
• West Pharmaceutical Services Inc.
• Merck
• Teva Pharmaceutical Industries Ltd
• GlaxoSmithKline PLC
• Holozymes Inc.
• Altaris
• Elcam Medical
• Fresenius Medical Care
• Philips Healthcare
• Novo Nordisk
• Teva Pharmaceutical
• Eli Lilly and Company
• CSL Behring
• Amgen Inc.

结论与建议

Drug Delivery Devices Market size was valued at USD 294.17 Billion in 2024 and is poised to grow from USD 311.52 Billion in 2025 to USD 492.79 Billion by 2033, growing at a CAGR of 5.9% during the forecast period (2026-2033).

The market for drug delivery devices is witnessing a significant surge, fueled by the increasing integration of advanced technologies that enhance targeted drug delivery. These devices are instrumental in minimizing side effects by ensuring optimized dosing, leading to a reduction in the overall required quantity of active ingredients and, consequently, lowering product costs. The rising interest in novel drug delivery solutions is spurring extensive research and development efforts, focusing on innovations that improve patient-friendliness, accessibility, and precision. This upward trend is further supported by the expansive growth of the biopharmaceutical sector, which is generating numerous new therapeutic treatments. Additionally, heightened investments from manufacturers in clinical trials, along with proactive regulatory involvement, is fostering a robust landscape for the advancement of innovative pharmaceuticals.

Top-down and bottom-up approaches were used to estimate and validate the size of the Drug Delivery Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Drug Delivery Devices Market Segments Analysis

Global Drug Delivery Devices Market is segmented into Route of Administration, Application, End-use, and region. By Route of Administration, the market is classified into Oral, Inhalation, Transdermal, Injectable, Ocular, Nasal, Topical, Others. Depending on the Application, it is categorized into Oncology, Infectious Diseases, Respiratory Diseases, Diabetes, Cardiovascular Diseases, Autoimmune Diseases, Central Nervous System Disorders, Others. According to End-use, the market is divided into Hospitals, Diagnostic Centers, Ambulatory Surgery Centers/Clinics, Home Care Settings, Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Drug Delivery Devices Market

The expansion of the Drug Delivery Devices market is significantly influenced by rising investment from the federal government, which is likely to accelerate growth. Additionally, both public and private sector advancements within the healthcare industry, particularly in developing regions, are expected to open up substantial market opportunities. Government initiatives aimed at delivering effective treatments for conditions such as cancer, infectious diseases, respiratory issues, diabetes, and cardiovascular diseases to underserved areas further enhance the potential for market development. This combination of funding, healthcare improvements, and targeted initiatives is poised to propel the market forward.

Restraints in the Drug Delivery Devices Market

The Drug Delivery Devices market faces challenges from various alternative systems, such as oral medications, intravenous injections, and transdermal patches, which vie for user preference. The selection of a particular drug administration method is influenced by numerous factors, including the specific medical requirements, individual patient preferences, and the characteristics of the medications themselves. These competing delivery options can limit the growth and adoption of subcutaneous drug delivery devices, as healthcare providers and patients weigh the benefits of each method against their unique circumstances and needs. As a result, the market encounters resistance in favor of these alternative solutions.

Market Trends of the Drug Delivery Devices Market

The Drug Delivery Devices market is witnessing a robust trend driven by the growing emphasis on biosimilars and biologics, with an increasing preference for subcutaneous administration methods. As healthcare providers seek more precise and targeted therapies for complex conditions, subcutaneous drug delivery systems have gained prominence due to their practicality and efficiency. This shift not only enhances patient compliance through ease of use but also supports the therapeutic effectiveness of biologics and biosimilars. Consequently, manufacturers are focusing on innovative designs and advanced technologies to cater to this demand, positioning subcutaneous delivery as a vital component in the evolving landscape of drug administration.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Technological Advancement
• Regulatory Landscape
• Value Chain Analysis
• Case Study Analysis
• PESTEL Analysis
• Market Attractiveness Index
• Pricing Analysis

Global Drug Delivery Devices Market Size by Route of Administration & CAGR (2026-2033)

• Market Overview
• Oral
• Inhalation
• Transdermal
• Injectable
• Ocular
• Nasal
• Topical
• Others

Global Drug Delivery Devices Market Size by Application & CAGR (2026-2033)

• Market Overview
• Oncology
• Infectious Diseases
• Respiratory Diseases
• Diabetes
• Cardiovascular Diseases
• Autoimmune Diseases
• Central Nervous System Disorders
• Others

Global Drug Delivery Devices Market Size by End-use & CAGR (2026-2033)

• Market Overview
• Hospitals
• Diagnostic Centers
• Ambulatory Surgery Centers/Clinics
• Home Care Settings
• Others

Global Drug Delivery Devices Market Size & CAGR (2026-2033)

• North America, (Route of Administration, Application, End-use)
  • US
  • Canada
• Europe, (Route of Administration, Application, End-use)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific, (Route of Administration, Application, End-use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America, (Route of Administration, Application, End-use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa, (Route of Administration, Application, End-use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Pfizer, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BD
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• UniQure N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sibiono GeneTech Co. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• West Pharmaceutical Services Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline PLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Holozymes Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Altaris
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elcam Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius Medical Care
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Philips Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novo Nordisk
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CSL Behring
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amgen Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation